NAV
$74.88
AUM
$710,930
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.00
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +7.77% | +0.41% | -8.08% | +39.40% | - | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | GSK | GSK PLC ADR | 97.64% |
The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (“ADRs”) of GSK plc (the “Company”). The series will not invest directly in the company. The fund is non-diversified.
Inception Date: 2025-01-06